Procedure
Methodology
Every price here is a reading taken off a company's own page on a stated day, then put through the same arithmetic as every other price on the site. This page is that procedure in full — the capture steps, the five ways a price gets captured wrong, and what a monthly number becomes over a year.
Last updated
Where this page sits
This is the procedure: the steps, the named failure modes, and the arithmetic, worked on rows that are on the site today. The commitments behind it — who writes this, what a commercial relationship can and cannot reach, what we do with an FDA warning letter, and what credentials we do not have — are on the editorial policy. Why any of it is worth doing at all — the gap between the advertised price and the one you are still paying in month seven — is on about Doseworth. No page repeats another.
Section 1
What this method has priced so far
Three counts, read straight out of the published data rather than typed here — which is also the first thing this page is demonstrating.
341
Priced rows
228
Charge more than they advertise
64
Bill every four weeks
228 of 341 priced rows charge more than the figure they lead with
One column per band, one row per compound per company. The gap is (walk-away price − advertised price) ÷ advertised price, on the standing no-commitment rate. Among the 228 rows that have a gap, the middle one is +50%. Captured August 2026 to September 2026.
Charges no more than it advertises: 113 rows
Up to 25% more than advertised: 48 rows
25 to 49% more than advertised: 64 rows
50 to 99% more than advertised: 67 rows
100 to 199% more than advertised — at least double: 27 rows
200% or more than advertised — at least triple: 22 rows
How much more than advertised
Read off the live review registry at build time — every row is one compound at one company, priced from that company’s own page on a stated day. There is no blended price for a company anywhere in this data, so no company appears here as a single point.
The tail on the right is not a rounding error. Those are rows where the figure a company leads with is a prepay rate, a first-order coupon, or a drug price quoted without a membership that is compulsory to buy it — each one a specific arithmetic mistake, and each one named in Section 3 below.
Section 2
How a price is captured
The same five steps run for every row, in this order. A price that cannot complete them does not get published — it is not softened, estimated or carried over from a previous quarter.
- 1
Open the company's own page
The pricing or checkout page on the company's own domain. Not an aggregator, not a comparison site, not a press release, not another publisher's table.
- 2
Load it clean
No stored session, no prior visit, nothing carried over. Providers run split tests, and a price shown to a returning visitor is not the price a new reader will see.
- 3
Go through the intake, not around it
Most of these are single-page apps whose marketing copy and whose checkout disagree. Where they do, the price the signup would actually charge is the one that counts — we read it out of what the application itself loads.
- 4
Ask what month two costs
The single most productive question on this site. A first-order rate is a real price for exactly one charge, and it is not the price of treatment.
- 5
Record the date and the URL
Both are required fields on every row. A row missing either fails validation and the site does not build, so an undated or unsourced number cannot ship by accident.
Section 3
The five ways a price gets captured wrong
These are not hypothetical. Each one is a specific arithmetic mistake that turns a real number on a real page into a figure nobody is charged, and between them they account for nearly every implausibly cheap price in this market. Three of the five are shown below on a row that is live on this site right now.
- Error 1
Prepay as monthly
A multi-month commitment price is printed with a “/mo” suffix, so a rate that only exists if you pay for three, six or twelve months up front reads as the price of one month.
- How you spot it
- A large headline number, a smaller “billed quarterly”, “3-month plan” or “save 40%” line near it, and a second, higher price that only appears once you decline the plan.
- What we publish instead
- We publish the price of one cycle with no commitment, and show the prepay number beside it rather than instead of it.
On a live row
Captured August 2026
Ro — Semaglutide — Wegovy
- Advertised
- $238
- Charged, with no commitment
- $498
- Over a year, at 12 charges
- $5,976 not $2,856
The headline understates the year by $3,120. See the working on the Ro review.
- Error 2
Introductory rate as the ongoing rate
A first-month or first-order promotional price is captured as the standing price, so the figure is correct for exactly one charge and wrong for every charge after it.
- How you spot it
- “Starting at”, “first month”, “new patients”, or a price that is a long way below every comparable provider. Ask what month two costs — that is the question the page usually will not answer.
- What we publish instead
- We price month two. An introductory rate is recorded as a note on the row, never as the row.
On a live row
Captured August 2026
Noom Med — Compounded semaglutide — Microdose GLP-1Rx
- Advertised
- $49
- Charged, with no commitment
- $179
- Over a year, at 13 charges
- $2,327 not $637
The headline understates the year by $1,690. See the working on the Noom Med review.
- Error 3
Per-day price read as a month
A “$X a day” figure is multiplied by 30 and treated as the monthly cost — or, worse, the per-day line on the page was itself computed from a different, lower price than the one being charged.
- How you spot it
- A per-day figure sitting under a monthly figure that it does not divide into. When those two numbers disagree, one of them is describing a plan the reader is not being offered.
- What we publish instead
- We reconcile every per-day figure against the monthly price on the same page, and publish the monthly price the provider actually charges for one cycle.
On a live row
Captured August 2026
Strut Health — Compounded injectable tirzepatide
- Advertised
- $199
- Charged, with no commitment
- $325
- Over a year, at 12 charges
- $3,900 not $2,388
The headline understates the year by $1,512. See the working on the Strut Health review.
- Error 4
Membership divided by twelve
An annual membership or program fee is divided by 12 and shown next to a medication price, so two separate charges on two separate schedules read as one monthly line.
- How you spot it
- A small monthly figure described as a membership, a program, a “care fee” or “support”, with no statement of when it is actually billed.
- What we publish instead
- Fees are priced on the schedule they are billed on. A yearly fee is a yearly fee, and it never gets folded into a monthly medication row.
No published row on this site is affected by this one. Pricing here is recorded per compound, with no single blended figure for a company anywhere in the data — which is the shape this error needs in order to hide. We still screen for it on every capture.
- Error 5
A financing payment quoted as the price
The monthly installment on a third-party loan or buy-now-pay-later arrangement is presented as what the treatment costs, which it is not — it is what the credit costs per month.
- How you spot it
- “As low as $X/mo”, a lender's name or logo, a term length in months, or an APR disclosure in small type.
- What we publish instead
- We publish the cash price. A financing offer is a lending product, and its installment is not a price for a medication.
No published row on this site is affected by this one. Pricing here is recorded per compound, with no single blended figure for a company anywhere in the data — which is the shape this error needs in order to hide. We still screen for it on every capture.
Section 4
The thirteenth charge
This one is not a capture error. The number on the page is accurate and the company is not hiding anything — what fails is the reader's assumption that “monthly” means twelve times. A four-week cycle comes round 13 times in a 365-day year, and the thirteenth charge is a full extra payment that appears in no headline anywhere.
- Walk-away price
- What one cycle costs at the standing, no-commitment rate — what you pay if you stop after it. No prepay tier, no first-month promotion, no bundle.
- Year at this price
- The walk-away price multiplied by the number of times it is actually billed in a year: 12 on a calendar-month cycle, 13 on a four-week cycle. It is the year at this dose only. Several sellers charge more as you titrate upward and most of them do not publish the ladder, so where we know it we say so in the row — but the column stays on one rule for every provider, because a figure we guessed for some and measured for others could not be compared at all.
Worked on a live row
LillyDirect — Tirzepatide — Zepbound 5 mg
- Price of one cycle
- $399
- What twelve of those would be
- $4,788
- What a year actually costs, at 13 charges
- $5,187
A difference of $399 that nothing on the page is concealing and nothing on the page is telling you either. Captured August 2026.
Every board and every review annualises on the cycle the company actually bills, and labels which one it is. We never quietly normalize a four-week cycle to a month to make two prices look comparable — that is the comparison being wrong, not the prices.
Section 5
What decides the order of a list
Every ranked surface on this site states its rule on the page itself. The /best boards list the companies that pay us a commission in a first group, then everyone else, and order each group by a number computed from the price data. The /cheapest boards have no partner group and sort on price alone. No sort on this site reads anything but that grouping and the prices.
| Surface | Sorted by | Anything pinned? |
|---|---|---|
| /cheapest/… | True-year cost — walk-away × the real billing cycle, ascending | Price only |
| /best/… | Partners first, then everyone else; true-year cost ascending within each group | Partners grouped first |
| /compare/… | Not ranked. Two companies side by side, per compound | Not ranked |
| /reviews/… | Not ranked. One row per compound, cheapest compound first | Not ranked |
The partner group comes from the list of affiliate programs we have signed, and that list cannot write to a price row: every figure a sort reads is the one read from the company's own page. What we are paid for, and what it does not buy, is set out on the disclosure page.
That rule stated in words is easy to agree with and hard to check. This is what it actually produces on the widest board the site publishes — every row on /cheapest/compounded-semaglutide placed on one dollar axis at its own verified price, and nothing else deciding where a mark lands.
114 published compounded semaglutide prices, from $75.58 to $1,434
One mark per row, at the walk-away price for a single cycle — the standing rate with no commitment. Marks that would overlap stack upward; none is moved sideways. The dashed line is the middle row, $199, which is a real published price rather than an average of two.
Cheapest
$75.58
Middle row
$199
Dearest
$1,434
- Collective — medication plus the required annual fee: $75.58 per cycle
- Embody — weekly injection: $79 per cycle
- Lean Meds: $79 per cycle
- Mondae — injection: $87 per cycle
- LumiMeds — injection: $89 per cycle
- Bayan Health — microdose injection: $99 per cycle
- Bayan Health — oral drops: $99 per cycle
- Strut Health — oral, lozenge: $99 per cycle
- WellMedr: $99 per cycle
- Pepti — injection: $109 per cycle
- Trava Health — injection: $118 per cycle
- Kongo: $119 per cycle
- Magnolia Regenerative Medicine — injection with B12: $119 per cycle
- Bayan Health — injection: $129 per cycle
- bmiMD: $129 per cycle
- Polly (formerly Piper) — injection: $135 per cycle
- No BS RX — injectable, low-dose program: $140 per cycle
- Yucca Health: $146 per cycle
- Fella Health — men's program: $149 per cycle
- Idgie Health — one month, all doses: $149 per cycle
- OrderlyMeds — injection: $149 per cycle
- Science & Co — injectable: $149 per cycle
- Strut Health — injectable + B6: $149 per cycle
- Superior Remedies — gLP-1 program, semaglutide or tirzepatide: $149 per cycle
- Goldspan Health — sublingual microdose, taken daily: $149 per cycle
- TOM Weight Loss — injection: $149 per cycle
- Precision Telemed — full program: $149.99 per cycle
- Trellis Vitality: $150 per cycle
- PeterMD — + B12: $154.95 per cycle
- Alan Health — injection: $158 per cycle
- Alloy — weekly injection: $169 per cycle
- Nova — oral daily dose: $169 per cycle
- Lighter You — injection: $169 per cycle
- Rx.com — one month, bought on its own: $175 per cycle
- Trimi Health: $175 per cycle
- Mochi Health: $178 per cycle
- Bodybuilding Health+ — one month: $179 per cycle
- Edessa — injectable, one month: $179 per cycle
- Henry Meds — sublingual: $179 per cycle
- No BS RX — injectable, standard program: $179 per cycle
- No BS RX — oral, low-dose program: $179 per cycle
- Vytora Health: $179 per cycle
- Lighter You — gLP-1 microdose injection, semaglutide or tirzepatide: $179 per cycle
- Noom Med — microdose GLP-1Rx: $179 per cycle
- SexyMD — microdose injection: $179 per cycle
- VevaRX — injection: $189 per cycle
- Remedy Meds — microdose: $189 per cycle
- CoreAge Rx: $190 per cycle
- HealthRX — one month, bought outright: $190 per cycle
- Nex Gen Health Rx — injection: $190 per cycle
- Eden: $198 per cycle
- Nova — weekly injection: $198 per cycle
- Andrew Meds — injection: $199 per cycle
- Auren Rx — injection: $199 per cycle
- Bliv — injection: $199 per cycle
- BreezeMeds — injection: $199 per cycle
- CareBareRX: $199 per cycle
- HumeCare+ — injection: $199 per cycle
- HumeCare+ — oral: $199 per cycle
- Joi + Blokes — program, medication included: $199 per cycle
- Measured: $199 per cycle
- No BS RX — oral, standard program: $199 per cycle
- Oria Meds — injection with B12: $199 per cycle
- Rehydra+ Wellness — injection: $199 per cycle
- Renlo Health — injectable: $199 per cycle
- Shed — injection: $199 per cycle
- Longevixx — injection: $199 per cycle
- The Edit Health — injection: $209 per cycle
- Belle Health — injection: $219 per cycle
- Clume Health — microdose and Maintain program, semaglutide or tirzepatide, oral or injectable: $219 per cycle
- Edessa — oral tablet, one month: $229 per cycle
- Goldspan Health — injection: $229 per cycle
- AHBARx: $249 per cycle
- DirectMeds — sublingual: $249 per cycle
- MyDrHank — oral, one month, bought on its own: $249 per cycle
- Peak Wellness — injection: $249 per cycle
- RX Bella — injectable: $249 per cycle
- Synergy Rx — injection: $249 per cycle
- TMates: $249 per cycle
- Alinwell — injection: $249 per cycle
- Enhance.MD: $249 per cycle
- Luvo Health — weekly injection: $249 per cycle
- Prime Doctor RX — injectable: $249 per cycle
- Vyvron — semaglutide or tirzepatide, weight management: $249 per cycle
- Oak Longevity: $250 per cycle
- Clume Health — signature program, full-dose semaglutide or tirzepatide, oral or injectable: $259 per cycle
- MyDrHank — injection, one month, bought on its own: $259 per cycle
- Ivim Health: $264.50 per cycle
- SexyMD — injection: $269 per cycle
- Try Ageless — weekly injection with B12: $279 per cycle
- Lighter You — oral tablet, taken daily: $279 per cycle
- Luvo Health — oral tablets: $279 per cycle
- Prime Doctor RX — oral tablet: $279 per cycle
- Found — semaglutide or tirzepatide, cash-pay plan: $289 per cycle
- DudeMeds — injection, one month, bought on its own: $295 per cycle
- DirectMeds — injection: $297 per cycle
- Henry Meds — weekly injection: $297 per cycle
- Zealthy — bundled plan: $297 per cycle
- Live Vital: $299 per cycle
- MangoRx — oral tablet: $299 per cycle
- MEDGm — injection: $299 per cycle
- SnagRx — weekly injection: $299 per cycle
- Synergy Rx — oral dissolving tablet: $299 per cycle
- Gala GLP-1: $299 per cycle
- Remedy Meds: $299 per cycle
- Sprout Health: $299 per cycle
- SkinnyRx — microdose, weekly injection: $349 per cycle
- SkinnyRx — weekly injection: $349 per cycle
- MEDGm — oral dissolving tablet: $369 per cycle
- Midi Health: $386 per cycle
- GOAL.MD — injection: $444 per cycle
- Pallas Health: $597 per cycle
- He & She MD — injection: $1,194 per cycle
- He & She MD — oral: $1,434 per cycle
The cluster is the useful part: a quote inside it is ordinary for this compound, and one well outside it is either a genuine outlier or a figure that has been captured wrong. That is the same question Section 3 asks of every price before it is published.
Section 6
What we deliberately do not compute
A cost site is judged as much on the numbers it refuses to print as on the ones it does. These are the ones we will not, and why.
Your copay
What a covered drug costs you depends on your specific plan's formulary tier, deductible position and pharmacy network on the day you fill it. No public source publishes a per-drug copay, so any site showing you one has modeled it and called the model a fact.
A dose, or a dose-adjusted price
We price what a company charges for a cycle of treatment. We do not state, imply or build arithmetic around what anyone should take — that is a prescribing decision and it is not ours to make.
A savings figure
“Save $2,400 a year” requires a baseline, and the baseline is always chosen to make the number large. We show what each option costs and let the subtraction be yours.
A quality score
There is no rating out of ten anywhere on this site. We have not assessed anyone's clinical care, and a number in a circle would imply we had.
Section 7
How often this is checked again
Prices in this market move on no schedule at all — a plan can restructure between a Tuesday and a Thursday. So every row carries the date it was read, visibly, next to the number it describes.
Prices
Re-read quarterlyEvery published row is captured again from scratch, by the same five steps. A re-verification is a fresh reading, not a glance to confirm the old one still looks right.
Terms, coverage and inclusions
Re-read quarterlyStates served, what a fee covers, and cancellation terms are checked on the same cycle and carry their own date, separate from the price.
FDA warning-letter status
Re-read quarterlyA letter shown as open long after FDA closed it out is a false, checkable statement about a real company. What a letter does and does not mean — and why one never delists a company here — is on the editorial policy.
Section 8
When this procedure produces a wrong number
It will. A capture misses a condition buried three screens into an intake, a plan restructures the week after we read it, an annualisation uses the wrong cycle. When that happens the fix is published as a fix — what was wrong, what it is now, and when it changed — on the corrections page, which is also where to send one.
If a price here does not match what a company is showing you, that is worth telling us about — a mismatch is either our capture error or a live change, and both are things we want to know within the day rather than at the next quarterly pass.